In the recent decades, the incidence of hepatocellular carcinoma (HCC) has been found to be increasing in males in some countries. In China, HCC ranked second of cancer mortality since 1990s. Hepatitis B and C viruses...In the recent decades, the incidence of hepatocellular carcinoma (HCC) has been found to be increasing in males in some countries. In China, HCC ranked second of cancer mortality since 1990s. Hepatitis B and C viruses (HBV and HCV) and dietary aflatoxin intake remain the major causative factors of HCC. Surgery plays a major role in the treatment of HCC, particularly for small HCC. Downstaging unresectable huge HCC to smaller HCC and followed by resection will probably be a new approach for further study. Liver transplantation is indicated for small HCC, however, some issues remain to be solved.Different modes of 'regional cancer therapy for HCC' have been tried. Systemic chemotherapy has been disappointing in the past but the future can be promising.Biotherapy, such as cytokines, differentiation inducers,anti-angiogenic agents, gene therapy and tumor vaccine will probably play a role, particularly in the prevention of tumor recurrence. HCC invasiveness is currently the major target of study. Tremendous works have been done at the molecular level, which will provide clues for biomarker of HCC progressionas well as targets for intervention.展开更多
1985年，基因重组人生长激素（recombinant human growth hormone，rhGH）问世，为广大矮身材患儿的治疗带来希望。随后，rhGH在临床得到迅速应用，其治疗的有效性得到广泛验证，关于rhGH的治疗范围、治疗方案、疗效以及安全性的研究日...1985年，基因重组人生长激素（recombinant human growth hormone，rhGH）问世，为广大矮身材患儿的治疗带来希望。随后，rhGH在临床得到迅速应用，其治疗的有效性得到广泛验证，关于rhGH的治疗范围、治疗方案、疗效以及安全性的研究日益深入。为规范rhGH的应用及矮身材儿童的诊治，展开更多
Spatiotemporal variations of Chinese Loess Plateau vegetation cover during 1981-2006 have been investigated using GIMMS and SPOT VGT NDVI data and the cause of vegetation cover changes has been analyzed, considering t...Spatiotemporal variations of Chinese Loess Plateau vegetation cover during 1981-2006 have been investigated using GIMMS and SPOT VGT NDVI data and the cause of vegetation cover changes has been analyzed, considering the climate changes and human activities. Vegetation cover changes on the Loess Plateau have experienced four stages as follows: (1) vegetation cover showed a continued increasing phase during 1981―1989; (2) vegetation cover changes came into a relative steady phase with small fluctuations during 1990―1998; (3) vegetation cover declined rapidly during 1999―2001; and (4) vegetation cover increased rapidly during 2002―2006. The vegetation cover changes of the Loess Plateau show a notable spatial difference. The vegetation cover has obviously increased in the Inner Mongolia and Ningxia plain along the Yellow River and the ecological rehabilitated region of Ordos Plateau, however the vegetation cover evidently decreased in the hilly and gully areas of Loess Plateau, Liupan Mountains region and the northern hillside of Qinling Mountains. The response of NDVI to climate changes varied with different vegetation types. NDVI of sandy land vegetation, grassland and cultivated land show a significant increasing trend, but forest shows a decreasing trend. The results obtained in this study show that the spatiotemporal variations of vegetation cover are the outcome of climate changes and human activities. Temperature is a control factor of the seasonal change of vegetation growth. The increased temperature makes soil drier and unfavors vegetation growth in summer, but it favors vegetation growth in spring and autumn because of a longer growing period. There is a significant correlation between vegetation cover and precipitation and thus, the change in precipitation is an important factor for vegetation variation. The improved agricultural production has resulted in an increase of NDVI in the farmland, and the implementation of large-scale vegetation construction has led to some beneficial effect in ecology展开更多
缺血性脑卒中是目前我国最主要的致死致残病因之一，而其中颅内外大血管急性闭塞是缺血性脑卒中病情严重、预后不良的亚型，导致了巨大的社会和经济负担。4．5h内静脉应用重组组织型纤溶酶原激活剂（recombinant human tissue type plas...缺血性脑卒中是目前我国最主要的致死致残病因之一，而其中颅内外大血管急性闭塞是缺血性脑卒中病情严重、预后不良的亚型，导致了巨大的社会和经济负担。4．5h内静脉应用重组组织型纤溶酶原激活剂（recombinant human tissue type plasminogen activator，rt．PA）作为处理急性缺血性脑卒中证据最充分的治疗方式，已在世界范围内广泛开展；但限于其相对严格的时间窗和适应证、禁忌证要求，接受溶栓治疗的患者比例相对较低。展开更多
The highly conserved Wnt secreted proteins are critical mediators of cell-to-cell signaling during development of animals. Recent biochemical and genetic analyses have led to significant insight into understanding how...The highly conserved Wnt secreted proteins are critical mediators of cell-to-cell signaling during development of animals. Recent biochemical and genetic analyses have led to significant insight into understanding how Wnt signals work. The catalogue of Wnt signaling components has exploded. We now realize that multiple extracellular, cytoplasmic, and nuclear components modulate Wnt signaling. Moreover, receptor-ligand specificity and multiple feedback loops determine Wnt signaling outputs. It is also clear that Wnt signals are required for adult tissue maintenance. Perturbations in Wnt signaling cause human degenerative diseases as well as cancer.展开更多
Human pluripotent stem cells represent a potentially unlimited source of functional pancreatic endocrine lineage cells. Here we report a highly efficient approach to induce human embryonic stem （ES） cells and induce...Human pluripotent stem cells represent a potentially unlimited source of functional pancreatic endocrine lineage cells. Here we report a highly efficient approach to induce human embryonic stem （ES） cells and induced pluripo- tent stem （iPS） cells to differentiate into mature insulin-producing cells in a chemical-defined culture system. The differentiated human ES cells obtained by this approach comprised nearly 25% insulin-positive cells as assayed by flow cytometry analysis, which released insulin/C-peptide in response to glucose stimuli in a manner comparable to that of adult human islets. Most of these insulin-producing cells co-expressed mature β cell-specific markers such as NKX6-1 and PDX1, indicating a similar gene expression pattern to adult islet β cells in vivo. In this study, we also demonstrated that EGF facilitates the expansion of PDXl-positive pancreatic progenitors. Moreover, our protocol also succeeded in efficiently inducing human iPS cells to differentiate into insuIin-producing ceils. Therefore, this work not only provides a new model to study the mechanism of human pancreatic specialization and maturation in vitro, but also enhances the possibility of utilizing patient-specific iPS cells for the treatment of diabetes.展开更多
文摘In the recent decades, the incidence of hepatocellular carcinoma (HCC) has been found to be increasing in males in some countries. In China, HCC ranked second of cancer mortality since 1990s. Hepatitis B and C viruses (HBV and HCV) and dietary aflatoxin intake remain the major causative factors of HCC. Surgery plays a major role in the treatment of HCC, particularly for small HCC. Downstaging unresectable huge HCC to smaller HCC and followed by resection will probably be a new approach for further study. Liver transplantation is indicated for small HCC, however, some issues remain to be solved.Different modes of 'regional cancer therapy for HCC' have been tried. Systemic chemotherapy has been disappointing in the past but the future can be promising.Biotherapy, such as cytokines, differentiation inducers,anti-angiogenic agents, gene therapy and tumor vaccine will probably play a role, particularly in the prevention of tumor recurrence. HCC invasiveness is currently the major target of study. Tremendous works have been done at the molecular level, which will provide clues for biomarker of HCC progressionas well as targets for intervention.
文摘1985年，基因重组人生长激素（recombinant human growth hormone，rhGH）问世，为广大矮身材患儿的治疗带来希望。随后，rhGH在临床得到迅速应用，其治疗的有效性得到广泛验证，关于rhGH的治疗范围、治疗方案、疗效以及安全性的研究日益深入。为规范rhGH的应用及矮身材儿童的诊治，
基金National Natural Science Foundation of China (Grant No. 40671019)the Knowledge Innovation Project of the Institute of Geographical Sciences and Natural Resources Research of Chinese Academy of Sciences
文摘Spatiotemporal variations of Chinese Loess Plateau vegetation cover during 1981-2006 have been investigated using GIMMS and SPOT VGT NDVI data and the cause of vegetation cover changes has been analyzed, considering the climate changes and human activities. Vegetation cover changes on the Loess Plateau have experienced four stages as follows: (1) vegetation cover showed a continued increasing phase during 1981―1989; (2) vegetation cover changes came into a relative steady phase with small fluctuations during 1990―1998; (3) vegetation cover declined rapidly during 1999―2001; and (4) vegetation cover increased rapidly during 2002―2006. The vegetation cover changes of the Loess Plateau show a notable spatial difference. The vegetation cover has obviously increased in the Inner Mongolia and Ningxia plain along the Yellow River and the ecological rehabilitated region of Ordos Plateau, however the vegetation cover evidently decreased in the hilly and gully areas of Loess Plateau, Liupan Mountains region and the northern hillside of Qinling Mountains. The response of NDVI to climate changes varied with different vegetation types. NDVI of sandy land vegetation, grassland and cultivated land show a significant increasing trend, but forest shows a decreasing trend. The results obtained in this study show that the spatiotemporal variations of vegetation cover are the outcome of climate changes and human activities. Temperature is a control factor of the seasonal change of vegetation growth. The increased temperature makes soil drier and unfavors vegetation growth in summer, but it favors vegetation growth in spring and autumn because of a longer growing period. There is a significant correlation between vegetation cover and precipitation and thus, the change in precipitation is an important factor for vegetation variation. The improved agricultural production has resulted in an increase of NDVI in the farmland, and the implementation of large-scale vegetation construction has led to some beneficial effect in ecology
文摘缺血性脑卒中是目前我国最主要的致死致残病因之一，而其中颅内外大血管急性闭塞是缺血性脑卒中病情严重、预后不良的亚型，导致了巨大的社会和经济负担。4．5h内静脉应用重组组织型纤溶酶原激活剂（recombinant human tissue type plasminogen activator，rt．PA）作为处理急性缺血性脑卒中证据最充分的治疗方式，已在世界范围内广泛开展；但限于其相对严格的时间窗和适应证、禁忌证要求，接受溶栓治疗的患者比例相对较低。
文摘The highly conserved Wnt secreted proteins are critical mediators of cell-to-cell signaling during development of animals. Recent biochemical and genetic analyses have led to significant insight into understanding how Wnt signals work. The catalogue of Wnt signaling components has exploded. We now realize that multiple extracellular, cytoplasmic, and nuclear components modulate Wnt signaling. Moreover, receptor-ligand specificity and multiple feedback loops determine Wnt signaling outputs. It is also clear that Wnt signals are required for adult tissue maintenance. Perturbations in Wnt signaling cause human degenerative diseases as well as cancer.
文摘Human pluripotent stem cells represent a potentially unlimited source of functional pancreatic endocrine lineage cells. Here we report a highly efficient approach to induce human embryonic stem （ES） cells and induced pluripo- tent stem （iPS） cells to differentiate into mature insulin-producing cells in a chemical-defined culture system. The differentiated human ES cells obtained by this approach comprised nearly 25% insulin-positive cells as assayed by flow cytometry analysis, which released insulin/C-peptide in response to glucose stimuli in a manner comparable to that of adult human islets. Most of these insulin-producing cells co-expressed mature β cell-specific markers such as NKX6-1 and PDX1, indicating a similar gene expression pattern to adult islet β cells in vivo. In this study, we also demonstrated that EGF facilitates the expansion of PDXl-positive pancreatic progenitors. Moreover, our protocol also succeeded in efficiently inducing human iPS cells to differentiate into insuIin-producing ceils. Therefore, this work not only provides a new model to study the mechanism of human pancreatic specialization and maturation in vitro, but also enhances the possibility of utilizing patient-specific iPS cells for the treatment of diabetes.
